29
Participants
Start Date
August 31, 2014
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
Oral Pentamidine
Oral pentamidine given at 300 mg, 600 mg, 900 mg or 1200 mg QD x 3 consecutive days
Placebo
Placebo given at 300 mg, 600 mg, 900 mg or 1200 mg QD x 3 consecutive days
Dr. Kelly Burak, Calgary
Dr Morris Sherman, Toronto
Dr Marc Bilodeau, Montreal
Lead Sponsor
Oncozyme Pharma Inc.
INDUSTRY